Literature DB >> 31538349

Role of lymph node stroma and microenvironment in T cell tolerance.

Vikas Saxena1,2, Lushen Li1,2, Christina Paluskievicz1,2, Vivek Kasinath3, Asher Bean3, Reza Abdi3, Christopher M Jewell4,5, Jonathan S Bromberg1,2.   

Abstract

Lymph nodes (LNs) are at the cross roads of immunity and tolerance. These tissues are compartmentalized into specialized niche areas by lymph node stromal cells (LN SCs). LN SCs shape the LN microenvironment and guide immunological cells into different zones through establishment of a CCL19 and CCL21 gradient. Following local immunological cues, LN SCs modulate activity to support immune cell priming, activation, and fate. This review will present our current understanding of LN SC subsets roles in regulating T cell tolerance. Three major types of LN SC subsets, namely fibroblastic reticular cells, lymphatic endothelial cells, and blood endothelial cells, are discussed. These subsets serve as scaffolds to support and regulate T cell homeostasis. They contribute to tolerance by presenting peripheral tissue antigens to both CD4 and CD8 T cells. The role of LN SCs in regulating T cell migration and tolerance induction is discussed. Looking forward, recent advances in bioengineered materials and approaches to leverage LN SCs to induce T cell tolerance are highlighted, as are current clinical practices that allow for manipulation of the LN microenvironment to induce tolerance. Increased understanding of LN architecture, how different LN SCs integrate immunological cues and shape immune responses, and approaches to induce T cell tolerance will help further combat autoimmune diseases and graft rejection.
© 2019 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  T cell; anergy; autoimmune disease; autoimmunity; lymph nodes; suppression; tolerance; transplantation

Mesh:

Substances:

Year:  2019        PMID: 31538349      PMCID: PMC6935411          DOI: 10.1111/imr.12799

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  168 in total

1.  Regulatory T cells recruited through CCL22/CCR4 are selectively activated in lymphoid infiltrates surrounding primary breast tumors and lead to an adverse clinical outcome.

Authors:  Michael Gobert; Isabelle Treilleux; Nathalie Bendriss-Vermare; Thomas Bachelot; Sophie Goddard-Leon; Vanessa Arfi; Cathy Biota; Anne Claire Doffin; Isabelle Durand; Daniel Olive; Solène Perez; Nicolas Pasqual; Christelle Faure; Isabelle Ray-Coquard; Alain Puisieux; Christophe Caux; Jean-Yves Blay; Christine Ménétrier-Caux
Journal:  Cancer Res       Date:  2009-02-24       Impact factor: 12.701

2.  Global lymphoid tissue remodeling during a viral infection is orchestrated by a B cell-lymphotoxin-dependent pathway.

Authors:  Varsha Kumar; Elke Scandella; Renzo Danuser; Lucas Onder; Maximilian Nitschké; Yoshinori Fukui; Cornelia Halin; Burkhard Ludewig; Jens V Stein
Journal:  Blood       Date:  2010-02-25       Impact factor: 22.113

3.  Activation of fibroblastic reticular cells in kidney lymph node during crescentic glomerulonephritis.

Authors:  Vivek Kasinath; Osman A Yilmam; Mayuko Uehara; Liwei Jiang; Farideh Ordikhani; Xiaofei Li; David J Salant; Reza Abdi
Journal:  Kidney Int       Date:  2018-12-03       Impact factor: 10.612

Review 4.  Regulation of the Immune System by Laminins.

Authors:  Thomas Simon; Jonathan S Bromberg
Journal:  Trends Immunol       Date:  2017-07-03       Impact factor: 16.687

5.  FTY720, a novel immunomodulator: efficacy and safety results from the first phase 2A study in de novo renal transplantation.

Authors:  Helio Tedesco-Silva; Georges Mourad; Barry D Kahan; Josep Grinyo Boira; Willem Weimar; Shamkant Mulgaonkar; Björn Nashan; Soren Madsen; Bernard Charpentier; Pascale Pellet; Yves Vanrenterghem
Journal:  Transplantation       Date:  2005-06-15       Impact factor: 4.939

6.  Lymph node fibroblastic reticular cells directly present peripheral tissue antigen under steady-state and inflammatory conditions.

Authors:  Anne L Fletcher; Veronika Lukacs-Kornek; Erika D Reynoso; Sophie E Pinner; Angelique Bellemare-Pelletier; Mark S Curry; Ai-Ris Collier; Richard L Boyd; Shannon J Turley
Journal:  J Exp Med       Date:  2010-03-22       Impact factor: 14.307

7.  Sphingosine 1-phosphate receptor agonists attenuate relapsing-remitting experimental autoimmune encephalitis in SJL mice.

Authors:  Michael Webb; Chui-Se Tham; Fen-Fen Lin; Karen Lariosa-Willingham; Naichen Yu; Jeffrey Hale; Suzanne Mandala; Jerold Chun; Tadimeti S Rao
Journal:  J Neuroimmunol       Date:  2004-08       Impact factor: 3.478

8.  Identification of vascular lineage-specific genes by transcriptional profiling of isolated blood vascular and lymphatic endothelial cells.

Authors:  Satoshi Hirakawa; Young-Kwon Hong; Natasha Harvey; Vivien Schacht; Kant Matsuda; Towia Libermann; Michael Detmar
Journal:  Am J Pathol       Date:  2003-02       Impact factor: 4.307

9.  Intra-lymph node injection of biodegradable polymer particles.

Authors:  James I Andorko; Lisa H Tostanoski; Eduardo Solano; Maryam Mukhamedova; Christopher M Jewell
Journal:  J Vis Exp       Date:  2014-01-02       Impact factor: 1.355

10.  The human lymph node microenvironment unilaterally regulates T-cell activation and differentiation.

Authors:  Konstantin Knoblich; Sara Cruz Migoni; Susan M Siew; Elizabeth Jinks; Baksho Kaul; Hannah C Jeffery; Alfie T Baker; Muath Suliman; Katerina Vrzalikova; Hisham Mehenna; Paul G Murray; Francesca Barone; Ye H Oo; Philip N Newsome; Gideon Hirschfield; Deirdre Kelly; Steven P Lee; Biju Parekkadan; Shannon J Turley; Anne L Fletcher
Journal:  PLoS Biol       Date:  2018-09-04       Impact factor: 8.029

View more
  15 in total

1.  Lymph node fibroblastic reticular cells regulate differentiation and function of CD4 T cells via CD25.

Authors:  Dongeon Kim; Mingyo Kim; Tae Woo Kim; Yong-Ho Choe; Hae Sook Noh; Hyun Min Jeon; HyunSeok Kim; Youngeun Lee; Gayeong Hur; Kyung-Mi Lee; Kihyuk Shin; Sang-Il Lee; Seung-Hyo Lee
Journal:  J Exp Med       Date:  2022-03-22       Impact factor: 14.307

2.  Spatial delivery of immune cues to lymph nodes to define therapeutic outcomes in cancer vaccination.

Authors:  James I Andorko; Shannon J Tsai; Joshua M Gammon; Sean T Carey; Xiangbin Zeng; Emily A Gosselin; Camilla Edwards; Shrey A Shah; Krystina L Hess; Christopher M Jewell
Journal:  Biomater Sci       Date:  2022-08-09       Impact factor: 7.590

Review 3.  The lymphatic vasculature: An active and dynamic player in cancer progression.

Authors:  Sara Rezzola; Elena C Sigmund; Cornelia Halin; Roberto Ronca
Journal:  Med Res Rev       Date:  2021-09-05       Impact factor: 12.388

4.  Lymph node fibroblastic reticular cells preserve a tolerogenic niche in allograft transplantation through laminin α4.

Authors:  Lushen Li; Marina W Shirkey; Tianshu Zhang; Wenji Piao; Xiaofei Li; Jing Zhao; Zhongcheng Mei; Yizhan Guo; Vikas Saxena; Allison Kensiski; Samuel J Gavzy; Yang Song; Bing Ma; Jing Wu; Yanbao Xiong; Long Wu; Xiaoxuan Fan; Holly Roussey; Meng Li; Alexæander S Krupnick; Reza Abdi; Jonathan S Bromberg
Journal:  J Clin Invest       Date:  2022-07-01       Impact factor: 19.456

5.  Imaging of fluorescent polymer dots in relation to channels and immune cells in the lymphatic system.

Authors:  Yufan Zhang; Juxiang Zhang; Xiaowei Li; Jingru Li; Shuting Lu; Yuqiao Li; Panting Ren; Chunfu Zhang; Liqin Xiong
Journal:  Mater Today Bio       Date:  2022-06-12

6.  Combined Identification of Novel Markers for Diagnosis and Prognostic of Classic Hodgkin Lymphoma.

Authors:  Zhixing Kuang; Jiannan Tu; Xun Li
Journal:  Int J Gen Med       Date:  2021-12-18

7.  Treg tissue stability depends on lymphotoxin beta-receptor- and adenosine-receptor-driven lymphatic endothelial cell responses.

Authors:  Vikas Saxena; Wenji Piao; Lushen Li; Christina Paluskievicz; Yanbao Xiong; Thomas Simon; Ram Lakhan; C Colin Brinkman; Sarah Walden; Keli L Hippen; Marina WillsonShirkey; Young S Lee; Chelsea Wagner; Bruce R Blazar; Jonathan S Bromberg
Journal:  Cell Rep       Date:  2022-04-19       Impact factor: 9.995

Review 8.  Variegated Outcomes of T Cell Activation by Dendritic Cells in the Steady State.

Authors:  Jessica Bourque; Daniel Hawiger
Journal:  J Immunol       Date:  2022-02-01       Impact factor: 5.426

9.  Simultaneous targeting of primary tumor, draining lymph node, and distant metastases through high endothelial venule-targeted delivery.

Authors:  Liwei Jiang; Sungwook Jung; Jing Zhao; Vivek Kasinath; Takaharu Ichimura; John Joseph; Paolo Fiorina; Andrew S Liss; Khalid Shah; Nasim Annabi; Nitin Joshi; Tomoya O Akama; Jonathan S Bromberg; Motohiro Kobayashi; Kenji Uchimura; Reza Abdi
Journal:  Nano Today       Date:  2020-12-14       Impact factor: 20.722

Review 10.  Targeting Dendritic Cells with Antigen-Delivering Antibodies for Amelioration of Autoimmunity in Animal Models of Multiple Sclerosis and Other Autoimmune Diseases.

Authors:  Courtney A Iberg; Daniel Hawiger
Journal:  Antibodies (Basel)       Date:  2020-06-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.